Best Biotech Fund? Biotech stocks resemble a landscape filled with craters. The two ETFs that cover the sector, IBB and FBT, are hurting badly, YTD, 1yr or 3yr. FBIOX is down about 15% YTD while broader-based HC funds have not kept up with the stock market as a whole. I owned CELG until it was bought up by BMY which I kept for a while. The stock rose to nearly $70, but it now trades for about $53. At one time it was a M* 5 star pick, but it turned out to be a value trap. I feel lucky to have exited when I did. For a pure growth HC fund, BHCFX has impressed, but it’s volatile.
December Commentary is posted …
Originally I'd hoped to name this site FundWatch.com. A squatter in the Netherlands wanted $25,000 for the URL so, no. (Mercer now owns it.) To the extent we have an active going-forward, it would be good to find a way to signal the fact that we care about pooled investment vehicles (PIVWatch?) and recognize that the wrapper makes a difference in only a few special instances (you can't close an ETF to new investments so in a capacity-constrained strategy, you need an OEF, as an example).
Cheers and holiday good wishes!
David
Interesting observations.
I looked up fundwatch.com and there is mercerfundwatch.com, a fund advisory for HK and Singapore. This "Mercer" (not related to the "Mercer family" in news in recent years) is a subsidiary of Marsh & McLennan/MMC.
I think that MFO - Mutual Fund Observer name caught on nicely.
There have been several instances where creation/redemption processes for ETFs were disrupted and then they traded just like CEFs at premium/discount. Of course, ETFs are not designed with this in mind, but that can happen. And ETNs (terrible sponsor IOUs) are famous for shutting at the worst possible times for their holders.
Fighting Inflation Without Getting Carried Away Stocks as inflation hedge - Prudent Speculator,
Market Watch in Barron's".....nine-plus decades of market history suggest that equities have gained ground, on average, whether inflation is rising or falling.....Yes, stocks have performed better when inflation is moving lower, but they have performed admirably on average, both concurrent with and subsequent to increases (as well as decreases) in the inflation rate over 12-month time spans, with value stocks and dividend payers leading the charge. The effect was not limited to 12-month periods. When we analyzed the numbers for shorter and longer periods, the take-home message that stocks seem to care little about inflation (in the aggregate) was similar.....we have crunched the numbers to see how stocks have performed when the rate is above 6%. Many may be surprised to learn that equities have performed better when inflation has been higher than when it has been lower, with value stocks enjoying sensational returns, on average, over those ensuing 176 periods. To be sure, while supposed market experts might argue otherwise, equities have long been a terrific hedge against inflation. -- John Buckingham and team"